Eczematous drug eruption after infliximab [1]

British Journal of Dermatology

Volumn 151, Issue 6, 2004, Pages 1272-1273

  Dumont Berset, M ^a   Laffitte, E ^a   Gerber, C ^a   Dudler, J ^a   Panizzon, R G ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHIMERIC ANTIBODY; ETANERCEPT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; STEROID; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ALLERGY; ANKYLOSING SPONDYLITIS; ARTHRITIS; BULLOUS SKIN DISEASE; CASE REPORT; CROHN DISEASE; DELAYED HYPERSENSITIVITY; DERMATITIS; DRUG ERUPTION; DRUG WITHDRAWAL; ECZEMA; ECZEMATOID LIKE PURPURA; ERYTHEMA MULTIFORME; HUMAN; HUMAN CELL; HUMAN TISSUE; INFUSION; LETTER; LEUKOCYTE COUNT; LEUKOCYTOCLASTIC VASCULITIS; LICHENOID ERUPTION; LOWER RESPIRATORY TRACT INFECTION; LUPUS ERYTHEMATOSUS; LYMPHOCYTIC INFILTRATION; MALE; PAPULAR SKIN DISEASE; PATCH TEST; PRIORITY JOURNAL; PROVOCATION TEST; PSORIASIS; PSORIATIC ARTHRITIS; PUSTULAR PSORIASIS; PUSTULOSIS PALMOPLANTARIS; RASH; RHEUMATOID ARTHRITIS; SKIN BIOPSY; SKIN EDEMA; UPPER RESPIRATORY TRACT INFECTION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; DRUG ERUPTIONS; ECZEMA; HUMANS; MALE;

EID: 11144310030     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06282.x     Document Type: Letter

References (7)

1. Devos SA, van den Bossche N, de Vos M, Naeyaert JM. Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy. Dermatology 2003; 206: 388-90.
2. Kent PD, Davis JM III, Davis MD, Matteson EL. Bullous skin lesions following infliximab infusion in a patient with rheumatoid arthritis. Arthritis Rheum 2002: 46: 2257-8; author reply 2259.
3. Vergara G, Silvestre JF, Betlloch I et al. Cutaneous drug eruption to infliximab: report of 4 cases with an interface dermatitis pattern. Arch Dermatol 2002; 138: 1258-9.
4. Wang LC, Medenica MM, Shea CR, Busbey S. Infliximab-induced eczematid-like purpura of Doucas and Kapetenakis. J Am Acad Dermatol 2003; 49: 157-8.
5. Gottlieb AB. Infliximab for psoriasis. J Am Acad Dermatol 2003; 49: S112-17.
6. Kiely PD, Johnson DM. Infliximab and leflunomide combination therapy in rheumatoid arthritis: an open-label study. Rheumatology (Oxford) 2002; 41: 631-7.
7. Wright RC. Atopic dermatitis-like eruption precipitated by infliximab. J Am Acad Dermatol 2003; 49: 160-1.